Innoviva, Inc.

INVANasdaq· Pharmaceutical Preparations

Price History

Revenue

$411.3M

▲ 14.7% YoY

Net Income

$271.2M

▲ 1059.2% YoY

EPS

$3.30

▲ 816.7% YoY

Cash

$550.9M

▲ 80.7% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.